Barrington Research Upgrades Anika Therapeutics (ANIK) to Outperform
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $21.50 +1.56%
Rating Summary:
4 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 9
Rating Summary:
4 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 9
Join SI Premium – FREE
Barrington Research analyst Michael Petusky upgraded Anika Therapeutics (NASDAQ: ANIK) from Market Perform to Outperform with a price target of $43.00.
For an analyst ratings summary and ratings history on Anika Therapeutics click here. For more ratings news on Anika Therapeutics click here.
Shares of Anika Therapeutics closed at $39.27 yesterday.
You May Also Be Interested In
- Berenberg Upgrades Accelleron Industries AG (ACLN:SW) to Buy
- Citi Upgrades Central Retail Corp PCL (CRC:TB) to Buy
- Citi Upgrades Shenzhen T&S Communication (300570:CH) to Neutral
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
